MétaCan
Menu
Back to cohort

Treatment outcome in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study (ESOS)

2017· article· en· W2587219500 on OpenAlexaff
Ariane L. Herrick, Xiaoyan Pan, Sébastien Peytrignet, Mark Lunt, Roger Hesselstrand, Luc Mouthon, Alan J. Silman, Edith Brown, László Czirják, Jörg H. W. Distler, Oliver Distler, Kim Fligelstone, William J Gregory, Rachel Ochiel, Codrina Ancuța, Voon H Ong, Dominique Farge, Marie Hudson, Marco Matucci‐Cerinic, Alexandra Balbir‐Gurman, Øyvind Midtvedt, Alison Jordan, Paresh Jobanputra, Wendy Stevens, Pia Moinzadeh, Frances Hall, C. Agard, Marina Anderson, Élisabeth Diot, Rajan Madhok, Mohammed Akil, Maya H Buch, Nemanja Damjanov, Harsha Gunawardena, Peter Lanyon, Yasmeen Ahmad, Kuntal Chakravarty, Søren Jacobsen, Alex J. MacGregor, Neil McHugh, Ulf Müller‐Ladner, Gabriela Riemekasten, Michael Becker, Janet Roddy, Patrícia Carreira, Anne Laure Fauchais, É. Hachulla, J. Hamilton, Murat İnanç, John S McLaren, Jacob M. van Laar, Sanjay Pathare, Susannah Proudman, Anna Rudin, Joanne Sahhar, B. Coppéré, J. Serratrice, Tom Sheeran, Douglas J. Veale, C. Grangé, Georges-Selim Trad, Christopher P. Denton

Bibliographic record

VenueAnnals of the Rheumatic Diseases · 2017
Typearticle
Languageen
FieldMedicine
TopicSystemic Sclerosis and Related Diseases
Canadian institutionsMcGill UniversityJewish General Hospital
FundersPharmacyclicsGenentechMedacGilead SciencesEuropean League Against RheumatismBristol-Myers SquibbEli Lilly and CompanyAstraZenecaCSL BehringArray BioPharmaSanofiScleroderma and Raynaud's UKPfizerActive BiotechCelgene
KeywordsMedicineScleroderma (fungus)Observational studyDermatologyOutcome (game theory)Internal medicinePathology

Abstract

fetched live from OpenAlex

OBJECTIVES: The rarity of early diffuse cutaneous systemic sclerosis (dcSSc) makes randomised controlled trials very difficult. We aimed to use an observational approach to compare effectiveness of currently used treatment approaches. METHODS: This was a prospective, observational cohort study of early dcSSc (within three years of onset of skin thickening). Clinicians selected one of four protocols for each patient: methotrexate, mycophenolate mofetil (MMF), cyclophosphamide or 'no immunosuppressant'. Patients were assessed three-monthly for up to 24 months. The primary outcome was the change in modified Rodnan skin score (mRSS). Confounding by indication at baseline was accounted for using inverse probability of treatment (IPT) weights. As a secondary outcome, an IPT-weighted Cox model was used to test for differences in survival. RESULTS: Of 326 patients recruited from 50 centres, 65 were prescribed methotrexate, 118 MMF, 87 cyclophosphamide and 56 no immunosuppressant. 276 (84.7%) patients completed 12 and 234 (71.7%) 24 months follow-up (or reached last visit date). There were statistically significant reductions in mRSS at 12 months in all groups: -4.0 (-5.2 to -2.7) units for methotrexate, -4.1 (-5.3 to -2.9) for MMF, -3.3 (-4.9 to -1.7) for cyclophosphamide and -2.2 (-4.0 to -0.3) for no immunosuppressant (p value for between-group differences=0.346). There were no statistically significant differences in survival between protocols before (p=0.389) or after weighting (p=0.440), but survival was poorest in the no immunosuppressant group (84.0%) at 24 months. CONCLUSIONS: These findings may support using immunosuppressants for early dcSSc but suggest that overall benefit is modest over 12 months and that better treatments are needed. TRIAL REGISTRATION NUMBER: NCT02339441.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.001
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.014
Threshold uncertainty score0.570

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.001
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0010.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.237
GPT teacher head0.353
Teacher spread0.116 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations139
Published2017
Admission routes1
Has abstractyes

Explore more

Same venueAnnals of the Rheumatic DiseasesSame topicSystemic Sclerosis and Related DiseasesFrench-language works237,207